Dr. McNair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
WIRB-Copernicus Group
212 Carnegie Center, Suite 310
Princeton, NJ 08540
Education & Training
Boston University Medical CenterResidency, Surgery, 1995 - 2000
Uconn School Of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 2000 - 2025
Publications & Presentations
PubMed
- 193 citationsAntiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis CNicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer
Hepatology. 2007-09-01 - 309 citationsRapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized StudyHendrik W. Reesink, Stefan Zeuzem, Christine J. Weegink, Nicole Forestier, Andre van Vliet
Gastroenterology. 2006-10-01 - 850 citationsTelaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionJohn G. McHutchison, Gregory T. Everson, Stuart C. Gordon, Ira M. Jacobson, Mark S. Sulkowski
The New England Journal of Medicine. 2009-04-30
Press Mentions
Statement of Support for the FDASeptember 11th, 2020
Coronavirus Pandemic Brings Hundreds of U.S. Clinical Trials to A HaltApril 11th, 2020
Clinical Trial Reimbursement for Patients: Current Challenges and Future ImprovementsSeptember 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
